Thermo Fisher Scientific (TMO) Stock Forecast & Price Target

Thermo Fisher Scientific
Bull Case

Here are some ways that investors could benefit from investing in Thermo Fisher Scientific Inc.:

• Thermo Fisher Scientific Inc. recently demonstrated strong financial performance by beating analyst expectations in its most recent quarterly report, posting earnings per share of $6.03 against a consensus estimate of $5.71, while also exceeding revenue forecasts with $11.99 billion in sales compared to the expected $11.71 billion, indicating robust demand for its life sciences solutions and analytical instruments.
• The company has received a consensus rating of Moderate Buy from analysts, with an average price target of $619.41, which suggests potential upside from the current stock price of $603.43, reflecting institutional confidence in the firm's ability to maintain growth in the healthcare and research sectors.
• Thermo Fisher Scientific Inc. has raised its full-year 2026 earnings guidance to a range of $24.93 to $25.33 per share, surpassing the previous consensus estimate of $24.85, which signals management's confidence in sustained operational efficiency and revenue growth throughout the remainder of the fiscal year.
• Recent institutional activity shows significant accumulation of shares, with HighTower Advisors LLC increasing its holdings by 9.8% in the second quarter and the California State Teachers Retirement System adding over 282 million shares, suggesting that large investors are positioning themselves for long-term value in the company's diversified product portfolio.
• The stock has shown resilience with a 52-week high of $647.00 and a current price of $603.43, maintaining a relatively low beta of 0.85, which indicates that the stock may offer a defensive profile with less volatility compared to the broader market while still providing exposure to the growing life sciences tools and services industry.